Optimized UV-Spectrophotometric Assay to Screen Bacterial Uricase Activity Using Whole Cell Suspension

Overview

Journal Front Microbiol

Specialty Microbiology

Date 2022 May 2

PMID 35495677

Authors

Benoit Pugin

Serafina Pluss

Denisa Mujezinovic

Rikke C Nielsen

Christophe Lacroix

Affiliations

Soon will be listed here.

Abstract

Uricase catalyzes the conversion of uric acid into allantoin with concomitant reduction of molecular oxygen to hydrogen peroxide. In humans, uricase is not functional, thereby predisposing individuals to hyperuricemia, a metabolic disturbance associated with gout, chronic kidney disorders, and cardiovascular diseases. The efficacy of current therapies to treat hyperuricemia is limited, and novel approaches are therefore desired, for instance using uricase-expressing probiotic strains. Here, we evaluated UV-spectrophotometric and HO-based fluorescent assays to enable the rapid identification of uricase activity in a broad panel of lactobacilli, , and species. We highlighted abiotic (medium composition and mode of sterilization) and biotic (HO-producing strains) factors impacting the measurements' accuracy, and reported on the stepwise optimization of a simple, fast, and robust high-throughput UV-spectrophotometric method to screen uricase activity using whole bacterial suspension, thereby assessing both cell-associated and extracellular activity. The validity of the optimized assay, based on the monitoring of uric acid degradation at 300 nm, was confirmed liquid chromatography. Finally, a panel of 319 Qualified Presumption of Safety (QPS) strains of lactobacilli (18 species covering nine genera), (three species), and (four species) were screened for uricase activity using the optimized method. All 319 strains, but the positive control sp. DSM 1306, were uricase-negative, indicating that this activity is rare among these genera, especially in isolates from food or feces. Altogether, the UV-spectrophotometric high-throughput assay based on whole bacterial suspension reported here can be used to rapidly screen large microbial collections, by simultaneously detecting cell-associated and extracellular uricase activity, thereby accelerating the identification of uricolytic strains with therapeutic potential to treat hyperuricemia.

References

Khucharoenphaisan K, Sinma K . Production and partial characterization of uric acid degrading enzyme from new source Saccharopolyspora sp. PNR11. Pak J Biol Sci. 2011; 14(3):226-31. DOI: 10.3923/pjbs.2011.226.231. View

Sorensen L, Levinson D . Origin and extrarenal elimination of uric acid in man. Nephron. 1975; 14(1):7-20. DOI: 10.1159/000180432. View

Kahn K, Tipton P . Spectroscopic characterization of intermediates in the urate oxidase reaction. Biochemistry. 1998; 37(33):11651-9. DOI: 10.1021/bi980446g. View

Perez-Ruiz F, Jansen T, Tausche A, Juarez-Campo M, Karra Gurunath R, Richette P . Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout. Drugs Context. 2019; 8:212581. PMC: 6544139. DOI: 10.7573/dic.212581. View

Bongaerts G, Uitzetter J, Brouns R, Vogels G . Uricase of Bacillus fastidiosus. Properties and regulation of synthesis. Biochim Biophys Acta. 1978; 527(2):348-58. DOI: 10.1016/0005-2744(78)90349-2. View

Suzuki K, Sakasegawa S, Misaki H, Sugiyama M . Molecular cloning and expression of uricase gene from Arthrobacter globiformis in Escherichia coli and characterization of the gene product. J Biosci Bioeng. 2005; 98(3):153-8. DOI: 10.1016/S1389-1723(04)00259-2. View

Pridmore R, Pittet A, Praplan F, Cavadini C . Hydrogen peroxide production by Lactobacillus johnsonii NCC 533 and its role in anti-Salmonella activity. FEMS Microbiol Lett. 2008; 283(2):210-5. DOI: 10.1111/j.1574-6968.2008.01176.x. View

Wu X, Wakamiya M, Vaishnav S, Geske R, Montgomery Jr C, Jones P . Hyperuricemia and urate nephropathy in urate oxidase-deficient mice. Proc Natl Acad Sci U S A. 1994; 91(2):742-6. PMC: 43025. DOI: 10.1073/pnas.91.2.742. View

Bongaerts G, Vogels G . Uric acid degradation by Bacillus fastidiosus strains. J Bacteriol. 1976; 125(2):689-97. PMC: 236130. DOI: 10.1128/jb.125.2.689-697.1976. View

10.

Martin R, Suarez J . Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol. 2009; 76(2):400-5. PMC: 2805228. DOI: 10.1128/AEM.01631-09. View

11.

Shaaban M, Abdelmegeed E, Ali Y . Cloning, Expression, and Purification of Recombinant Uricase Enzyme from Pseudomonas aeruginosa Ps43 Using Escherichia coli. J Microbiol Biotechnol. 2015; 25(6):887-92. DOI: 10.4014/jmb.1410.10041. View

12.

Pacher P, Nivorozhkin A, Szabo C . Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol Rev. 2006; 58(1):87-114. PMC: 2233605. DOI: 10.1124/pr.58.1.6. View

13.

Lotfy W . Production of a thermostable uricase by a novel Bacillus thermocatenulatus strain. Bioresour Technol. 2007; 99(4):699-702. DOI: 10.1016/j.biortech.2007.01.048. View

14.

Mahler J . A new bacterial uricase for uric acid determination. Anal Biochem. 1970; 38(1):65-84. DOI: 10.1016/0003-2697(70)90156-9. View

15.

Hemmler D, Roullier-Gall C, Marshall J, Rychlik M, Taylor A, Schmitt-Kopplin P . Evolution of Complex Maillard Chemical Reactions, Resolved in Time. Sci Rep. 2017; 7(1):3227. PMC: 5468300. DOI: 10.1038/s41598-017-03691-z. View

16.

Koyama Y, Ichikawa T, Nakano E . Cloning, sequence analysis, and expression in Escherichia coli of the gene encoding the Candida utilis urate oxidase (uricase). J Biochem. 1996; 120(5):969-73. DOI: 10.1093/oxfordjournals.jbchem.a021514. View

17.

Finkelstein R, LANKFORD C . A bacteriotoxic substance in autoclaved culture media containing glucose and phosphate. Appl Microbiol. 1957; 5(2):74-9. PMC: 1057261. DOI: 10.1128/am.5.2.74-79.1957. View

18.

Hertzberger R, Arents J, Dekker H, Pridmore R, Gysler C, Kleerebezem M . H(2)O(2) production in species of the Lactobacillus acidophilus group: a central role for a novel NADH-dependent flavin reductase. Appl Environ Microbiol. 2014; 80(7):2229-39. PMC: 3993133. DOI: 10.1128/AEM.04272-13. View

19.

Nakashima T, Seki T, Matsumoto A, Miura H, Sato E, Niwano Y . Generation of reactive oxygen species from conventional laboratory media. J Biosci Bioeng. 2010; 110(3):304-7. DOI: 10.1016/j.jbiosc.2010.03.003. View

20.

Wu Y, Ye Z, Feng P, Li R, Chen X, Tian X . JL-3 isolated from "Jiangshui" ameliorates hyperuricemia by degrading uric acid. Gut Microbes. 2021; 13(1):1-18. PMC: 8007157. DOI: 10.1080/19490976.2021.1897211. View